Effects of neocarzinostatin -chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts
1996

Effects of neocarzinostatin-chimeric Fab conjugates on pancreatic cancer growth

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): E Otsuji, T Yamaguchi, H Tsuruta, Y Yata, H Nishi, K Okamoto, K Taniguchi, M Kato, T Kotani, K Kitamura, T Takahashi

Primary Institution: Kyoto Prefectural University of Medicine

Hypothesis

Can neocarzinostatin conjugated to chimeric Fab fragments effectively inhibit the growth of human pancreatic carcinoma?

Conclusion

ChA7Fab-NCS significantly suppressed the growth of pancreatic cancer in a mouse model.

Supporting Evidence

  • ChA7Fab-NCS showed a greater anti-tumor effect than A7-NCS or NCS alone.
  • Tumor growth was completely suppressed in the chA7Fab-NCS treated group.
  • ChA7Fab-NCS accumulated more rapidly in tumors compared to A7-NCS.

Takeaway

This study shows that a special drug combined with an antibody can stop pancreatic cancer from growing in mice.

Methodology

The study used a nude mouse model to test the anti-tumor effects of chA7Fab-NCS compared to A7-NCS and NCS alone.

Limitations

The study was conducted in a mouse model, which may not fully represent human responses.

Participant Demographics

Nude mice, specifically 8-week-old male BALB/C mice.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication